Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Institut Curie
City of Hope Medical Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Mayo Clinic
Mayo Clinic
National Cancer Institute (NCI)
Institut Curie
National Cancer Institute (NCI)
City of Hope Medical Center
Austrian Breast & Colorectal Cancer Study Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
University of Washington
Institut Cancerologie de l'Ouest
Palleos Healthcare GmbH
Wake Forest University Health Sciences
OHSU Knight Cancer Institute
Karolinska University Hospital
UNICANCER
Inova Health Care Services
Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine
University of Washington
Northwestern University
Samsung Medical Center
Vanderbilt-Ingram Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Gustave Roussy, Cancer Campus, Grand Paris
Georgetown University
University Health Network, Toronto
The Netherlands Cancer Institute
M.D. Anderson Cancer Center
Washington University School of Medicine
Ohio State University Comprehensive Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
NYU Langone Health
Mayo Clinic